Two new treatments which could help the most vulnerable beat Covid-19 could be available on the NHS within weeks.

Thousands of courses of the antivirals have been secured by the government to be ready for use this winter, subject to approval by the UK medicines regulator.

The treatments, from pharmaceutical companies Merck Sharp and Dohme (MSD), and Pfizer, would be aimed at those most at risk from the virus, including the elderly and those with weakened immune systems.

This is a breaking news story, more to follow soon… Check back shortly for further updates.

Got a story? Get in touch with our news team by emailing us at [email protected]. Or you can submit your videos and pictures here.

For more stories like this, check our news page.

Follow Metro.co.uk on Twitter and Facebook for the latest news updates. You can now also get Metro.co.uk articles sent straight to your device. Sign up for our daily push alerts here.

Source: Read Full Article